Related Experiment Video
Updated: Jun 9, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss
Alicia M Cole1, Kevin Myant, Karen R Reed
1Beatson Institute of Cancer Research, Glasgow, United Kingdom; School of Biosciences, Cardiff, United Kingdom.
Abstract:
Inactivation of the Apc gene is recognized as the key early event in the development of sporadic colorectal cancer (CRC), where its loss leads to constitutive activation of β-catenin/T-cell factor 4 signaling and hence transcription of Wnt target genes such as c-Myc. Our and other previous studies have shown that although cyclin D1 is required for adenoma formation, it is not immediately upregulated following Apc loss within the intestine, suggesting that proliferation following acute Apc loss may be dependent on another D-type cyclin. In this study, we investigated the expression and functional relevance of cyclin D2 following Apc loss in the intestinal epithelium. Cyclin D2 is upregulated immediately following Apc loss, which corresponded with a significant increase in cyclin-dependent kinase 4 (CDK4) and hyperphosphorylated Rb levels. Deficiency of cyclin D2 resulted in a reduction in enterocyte proliferation and crypt size within Apc-deficient intestinal epithelium. Moreover, cyclin D2 dramatically reduced tumor growth and development in Apc(Min/+) mice. Importantly, cyclin D2 knockout did not affect proliferation of normal enterocytes, and furthermore, CDK4/6 inhibition also suppressed the proliferation of adenomatous cells and not normal cells from Apc(Min/+) mice. Taken together, these results indicate that cyclin D-CDK4/6 complexes are required for the efficient proliferation of cells with deregulated Wnt signaling, and inhibiting this complex may be an effective chemopreventative strategy in CRC.
Insights
Apc gene inactivation triggers colorectal cancer (CRC) by activating Wnt signaling. Cyclin D2, not cyclin D1, drives proliferation after Apc loss, offering a potential therapeutic target for CRC prevention.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Apc gene inactivation is a critical early step in sporadic colorectal cancer (CRC) development.
- Loss of Apc leads to constitutive Wnt signaling activation, promoting transcription of target genes like c-Myc.
- While cyclin D1 is necessary for adenoma formation, its delayed upregulation post-Apc loss suggests involvement of other D-type cyclins in intestinal proliferation.
Purpose of the Study:
- To investigate the expression and functional significance of cyclin D2 in the intestinal epithelium following Apc loss.
- To determine if cyclin D2 plays a role in the immediate proliferative response to acute Apc loss.
- To evaluate cyclin D2 as a potential therapeutic target for colorectal cancer.
Main Methods:
- Investigated cyclin D2 expression in the intestinal epithelium after Apc loss.
- Assessed the impact of cyclin D2 deficiency on enterocyte proliferation and crypt size in Apc-deficient models.
- Evaluated the effect of cyclin D2 on tumor growth and development in Apc(Min/+) mice.
- Examined the impact of CDK4/6 inhibition on normal and adenomatous cells from Apc(Min/+) mice.
Main Results:
- Cyclin D2 is upregulated immediately following Apc loss, coinciding with increased cyclin-dependent kinase 4 (CDK4) and hyperphosphorylated Rb levels.
- Cyclin D2 deficiency reduced enterocyte proliferation and crypt size in Apc-deficient intestines.
- Cyclin D2 deficiency significantly inhibited tumor growth and development in Apc(Min/+) mice.
- CDK4/6 inhibition suppressed proliferation of adenomatous cells but not normal enterocytes in Apc(Min/+) mice.
Conclusions:
- Cyclin D-CDK4/6 complexes are essential for the proliferation of cells with deregulated Wnt signaling.
- Targeting the cyclin D-CDK4/6 complex represents a promising chemopreventative strategy for colorectal cancer.
- Cyclin D2 is a key mediator of proliferation following Apc loss in the intestinal epithelium.
Related Concept Videos
Anaphase Promoting Complex
Anaphase Promoting Complex
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules

